Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage

Neurosurgery

Volumn 62, Issue 2, 2008, Pages 422-427

  Kramer, Andreas H ^a,e   Gurka, Matthew J ^b   Nathan, Bart ^c   Dumont, Aaron S ^c   Kassell, Neal F ^c   Bleck, Thomas P ^d  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e FOOTHILLS HOSPITAL   (Canada)

Author keywords

Cerebral aneurysm; Simvastatin; Statin; Subarachnoid hemorrhage; Transcranial Doppler; Vasospasm

Indexed keywords

ATORVASTATIN; DEXAMETHASONE; NIMODIPINE; PRAVASTATIN; SIMVASTATIN; VERAPAMIL;

ADULT; ANALYTIC METHOD; ARTICLE; BRAIN VASOSPASM; COIL EMBOLIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; DEATH; DISABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PERSISTENT VEGETATIVE STATE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK REDUCTION; SUBARACHNOID HEMORRHAGE;

BRAIN ISCHEMIA; COHORT STUDIES; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SIMVASTATIN; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

EID: 41749089775     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.neu.0000316009.19012.e3     Document Type: Article

References (30)

1. Anonymous: Epidemiology of aneurysmal subarachnoid hemorrhage in Australia and New Zealand: Incidence and case fatality from the Australasian Cooperative Research on Subarachnoid Hemorrhage Study (ACROSS). Stroke 31:1843-1850, 2000.
2. Anonymous: Report of World Federation of Neurological Surgeons Committee on a universal subarachnoid hemorrhage grading scale. J Neurosurg 68:985-986, 1988.
3. Barker FG 2nd, Ogilvy CS: Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: Ametaanalysis. J Neurosurg 84:405-414, 1996.
4. Claassen J, Bernardini GL, Kreiter K, Bates J, Du YE, Copeland D, Connolly ES, Mayer SA: Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemnorrhage: The Fisher scale revisited. Stroke 32:2012-2020, 2001.
5. Dorhout Mees SM, Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, van Gijn J: Calcium antagonists for aneurysmal subarachnoid hemorrhage. Cochrane Database Syst Rev 25:CD000277, 2007.
6. Dorsch NW, King MT: A review of cerebral vasospasm in aneurysmal subarachnoid hemorrhage. Part 1: Incidence and effects. J Clin Neurosci 1:19-26, 1994.
7. Hackett ML, Anderson CS: Health outcomes 1 year after subarachnoid hemorrhage: An international population-based study. The Australian Cooperative Research on Subarachnoid Hemorrhage Study Group. Neurology 55:658-662, 2000.
8. Haley EC Jr, Kassell NF, Torner JC: A randomized trial of nicardipine in subarachnoid hemorrhage: Angiographic and transcranial Doppler ultrasound results. A report of the Cooperative Aneurysm Study. J Neurosurg 78:548-553, 1993.
9. Hijdra A, van Gijn J, Nagelkerke NJ, Vermeulen M, van Crevel H: Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurismal subarachnoid hemorrhage. Stroke 19:1250-1256, 1988.
10. Hop JW, Rinkel GJ, Algra A, van Gijn J: Case-fatality rates and functional outcome after subarachnoid hemorrhage: A systematic review. Stroke 28:660-664, 1997.
11. Jennett B, Bond M: Assessment of outcome after severe brain damage. Lancet 1:480-484, 1975.
12. Kassell NF, Torner JC, Haley EC Jr, Jane JA, Adams HP, Kongable GL: The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. J Neurosurg 73:18-36, 1990.
13. Lynch JR, Wang H, McGirt MJ, Floyd J, Friedman AH, Coon AL, Blessing R, Alexander MJ, Graffagnino C, Warner DS, Laskowitz DT: Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: Results of a pilot randomized clinical trial. Stroke 36:2024-2026, 2005.
14. Lysakowski C, Walder B, Costanza MC, Tramer MR: Transcranial Doppler versus angiography in patients with vasospasm due to a ruptured cerebral aneurysm: A systematic review. Stroke 32:2292-2299, 2001.
15. Macdonald RL: Management of cerebral vasospasm. Neurosurg Rev 29:179-193, 2006.
16. Mayberg MR, Batjer HH, Dacey R, Diringer M, Haley EC, Heros RC, Sternau LL, Torner J, Adams HP Jr, Feinberg W: Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Circulation 90:2592-2605, 1994.
17. Mayer SA, Kreiter KT, Copeland D, Bernardini GL, Bates JE, Peery S, Claassen J, Du YE, Connolly ES Jr: Global and domain-specific cognitive impairment and outcome after subarachnoid hemorrhage. Neurology 59:1750-1758, 2002.
18. McGirt MJ, Blessing R, Alexander MJ, Nimjee SM, Woodworth GF, Friedman AH, Graffagnino C, Laskowitz DT, Lynch JR: Risk of cerebral vasospasm after subarachnoid hemorrhage reduced by statin therapy: A multivariate analysis of an institutional experience. J Neurosurg 105:671-674, 2006.
19. McGirt MJ, Lynch JR, Parra A, Sheng H, Pearlstein RD, Laskowitz DT, Pelligrino DA, Warner DS: Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke 33:2950-2956, 2002.
20. Nolan CP, Macdonald RL: Can angiographic vasospasm be used as a surrogate marker in evaluating therapeutic interventions for cerebral vasospasm? Neursurg Focus 21:E1, 2006.
21. Parra A, Kreiter KT, Williams S, Sciacca R, Mack WJ, Naidech AM, Commichau CS, Fitzsimmons BF, Janjua N, Mayer SA, Connolly ES Jr: Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurismal subarachnoid hemorrhage: A matched controlled cohort study. Neurosurgery 56:476-484, 2006.
22. Rabinstein AA, Weigand S, Atkinson JL, Wijdicks EF: Patterns of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke 36:992-997, 2005.
23. Singhal AB, Topcuoglu MA, Dorer DJ, Ogilvy CS, Carter BS, Koroshetz WJ: SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage. Neurology 64:1008-1013, 2005.
24. Stegmayr B, Eriksson M, Asplund K: Declining mortality from subarachnoid hemorrhage: Changes in incidence and case fatality from 1985 through 2000. Stroke 35:2059-2063, 2004.
25. Suarez JL, Tarr RW, Selman WR: Aneurysmal subarachnoid hemorrhage. N Engl J Med 354:387- 396, 2006.
26. Tseng MY, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ: Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: A phase II randomized placebo-controlled trial. Stroke 36:1627-1632, 2005.
27. Tseng MY, Hutchinson PJ, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ: Effects of acute pravastatin treatment on intensity of rescue therapy, length of inpatient stay, and 6 month outcome in patients after aneurysmal subarachnoid hemorrhage. Stroke 38:1545-1550, 2007.
28. van Gijn J, Kerr RS, Rinkel GJ: Subarachnoid hemorrhage. Lancet 369:306-318, 2007.
29. Vaughan CJ, Delanty N: Neuroprotective properties of statins in cerebral ischemia and stroke. Stroke 30:1969-1973, 1999.
30. Wintermark M, Ko NU, Smith WS, Liu S, Higashida RT, Dillon WP: Vasospasm after subarachnoid hemorrhage: Utility of perfusion CT and CT angiography on diagnosis and management. AJNR Am J Neuroradiol 27:26-34, 2006.